Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-056198

EVP, Chief Development Officer bought 25,000 shares at $1.09 ($27,250)

From the SEC's structured data for this filing

Trades in this filing

Forbes William P · EVP, Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-11-17 Purchase : show line 1 in the form +25,000 $1.09 $27,250 79,000 D
Open-market purchases · 25,000 sh · avg $1.09 · $27,250
Loading xslF345X05/doc4.xml…